Kaken Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	19,435	9,796	6,817	13,885	18,657
Depreciation & Amortization	2,554	2,753	2,568	2,486	2,318
Loss (Gain) From Sale of Assets	1,555	167	1,911	2,896	-333
Loss (Gain) From Sale of Investments	287	-13	-1	-1	-115
Other Operating Activities	-842	-3,788	-4,407	-4,431	-5,517
Change in Accounts Receivable	3,577	-4,559	972	392	1,251
Change in Inventory	-1,084	-1,603	-583	241	-2,923
Change in Accounts Payable	1,100	880	280	-2,630	-112
Change in Other Net Operating Assets	3,198	-1,056	1,696	498	1,154
Operating Cash Flow	29,780	2,577	9,253	13,336	14,380
Operating Cash Flow Growth	1055.61%	-72.15%	-30.62%	-7.26%	-47.65%
Capital Expenditures	-4,138	-1,861	-1,987	-2,986	-1,973
Sale of Property, Plant & Equipment	-	1	12	704	874
Cash Acquisitions	-15,378	-	-	-4,975	-
Sale (Purchase) of Intangibles	-254	-306	-219	-271	-313
Investment in Securities	120	516	-195	5	124
Other Investing Activities	-	-4,204	-238	-365	-356
Investing Cash Flow	-19,650	-5,854	-2,627	-7,888	-1,644
Issuance of Common Stock	7,764	-	-	-	-
Repurchase of Common Stock	-5,935	-	-1,340	-2,414	-2,940
Common Dividends Paid	-7,198	-5,657	-5,649	-5,714	-5,811
Other Financing Activities	-	-1	-1	-1	-1
Financing Cash Flow	-5,369	-5,658	-6,990	-8,129	-8,752
Miscellaneous Cash Flow Adjustments	-1	-	-	1	-1
Net Cash Flow	4,760	-8,935	-364	-2,680	3,983
Free Cash Flow	25,642	716	7,266	10,350	12,407
Free Cash Flow Growth	3481.28%	-90.15%	-29.80%	-16.58%	-50.98%
Free Cash Flow Margin	27.27%	0.99%	9.96%	13.61%	16.55%
Free Cash Flow Per Share	671.92	18.97	193.39	272.53	321.51
Cash Interest Paid	28	17	17	17	17
Cash Income Tax Paid	836	3,788	4,409	4,431	5,516
Levered Free Cash Flow	22,980	-1,299	7,486	8,025	9,418
Unlevered Free Cash Flow	22,998	-1,289	7,497	8,036	9,429
Change in Working Capital	6,791	-6,338	2,365	-1,499	-630

Source: S&P Global Market Intelligence. Standard template. Financial Sources.